kolaviron has been researched along with Parkinsonian Disorders in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Abah, VO; Awogbindin, IO; Ezekiel, IO; Farombi, EO; Izomoh, ER; Owoeye, O | 1 |
| Adeniyi, PA; Agedah, AE; Awogbindin, IO; Farombi, EO; Ogbuewu, E; Olorunkalu, PD; Oyetunde, BF | 1 |
| Abah, VO; Adebambo, OI; Aladelokun, OB; Awogbindin, IO; Ezekiel, IO; Farombi, EO; Farombi, TH; Izomoh, ER; Oladele, JO | 1 |
3 other study(ies) available for kolaviron and Parkinsonian Disorders
| Article | Year |
|---|---|
Kolaviron ameliorates behavioural deficit and injury to striatal dopaminergic terminals via modulation of oxidative burden, DJ-1 depletion and CD45R
Topics: Animals; Corpus Striatum; Dopaminergic Neurons; Flavonoids; Leukocyte Common Antigens; Locomotion; Male; Mice; Mice, Inbred BALB C; Oxidative Stress; Parkinsonian Disorders; Plant Extracts; Protein Deglycase DJ-1 | 2020 |
Kolaviron protects against nigrostriatal degeneration and gut oxidative damage in a stereotaxic rotenone model of Parkinson's disease.
Topics: Animals; Corpus Striatum; Dopaminergic Neurons; Flavonoids; Gastrointestinal Microbiome; Male; Nerve Degeneration; Neuroprotective Agents; Parkinsonian Disorders; Plant Extracts; Rats; Rotenone; Stereotaxic Techniques; Substantia Nigra | 2020 |
Neuroprotective role of kolaviron in striatal redo-inflammation associated with rotenone model of Parkinson's disease.
Topics: alpha-Synuclein; Animals; Anti-Inflammatory Agents; Antiparkinson Agents; Apoptosis; Behavior, Animal; Corpus Striatum; Cytokines; Disease Models, Animal; Exploratory Behavior; Flavonoids; Inflammation Mediators; Locomotion; Male; Neurons; Neuroprotective Agents; Oxidative Stress; Parkinsonian Disorders; Rats, Wistar; Reactive Oxygen Species; Rotenone; Tyrosine 3-Monooxygenase | 2019 |